BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9645617)

  • 1. Regulation of in vitro and in vivo T cell activation by CD43.
    Thurman EC; Walker J; Jayaraman S; Manjunath N; Ardman B; Green JM
    Int Immunol; 1998 May; 10(5):691-701. PubMed ID: 9645617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of mononuclear cell activation by an anti-CD43 (sialophorin) agonistic antibody.
    Silverman LB; Wong RC; Remold-O'Donnell E; Vercelli D; Sancho J; Terhorst C; Rosen F; Geha R; Chatila T
    J Immunol; 1989 Jun; 142(12):4194-200. PubMed ID: 2542404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of CD43 fails to alter T cell development and responsiveness.
    Carlow DA; Corbel SY; Ziltener HJ
    J Immunol; 2001 Jan; 166(1):256-61. PubMed ID: 11123300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation via the CD43 coreceptor augments T cell proliferation during the early phase of antigen-induced activation.
    Hamad M; Mosley RL; Wang J; Klein JR
    Dev Comp Immunol; 1996; 20(1):77-82. PubMed ID: 8738938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukosialin (CD43)-major histocompatibility class I molecule interactions involved in spontaneous T cell conjugate formation.
    Stöckl J; Majdic O; Kohl P; Pickl WF; Menzel JE; Knapp W
    J Exp Med; 1996 Nov; 184(5):1769-79. PubMed ID: 8920865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engagement of CD43 enhances human immunodeficiency virus type 1 transcriptional activity and virus production that is induced upon TCR/CD3 stimulation.
    Barat C; Tremblay MJ
    J Biol Chem; 2002 Aug; 277(32):28714-24. PubMed ID: 12045189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disregulated expression of CD43 (leukosialin, sialophorin) in the B cell lineage leads to immunodeficiency.
    Ostberg JR; Dragone LL; Driskell T; Moynihan JA; Phipps R; Barth RK; Frelinger JG
    J Immunol; 1996 Dec; 157(11):4876-84. PubMed ID: 8943391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site.
    Sperling AI; Sedy JR; Manjunath N; Kupfer A; Ardman B; Burkhardt JK
    J Immunol; 1998 Dec; 161(12):6459-62. PubMed ID: 9862667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD43 regulation of T cell activation is not through steric inhibition of T cell-APC interactions but through an intracellular mechanism.
    Tong J; Allenspach EJ; Takahashi SM; Mody PD; Park C; Burkhardt JK; Sperling AI
    J Exp Med; 2004 May; 199(9):1277-83. PubMed ID: 15117976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum immunobioactivity of murine small intestinal intraepithelial lymphocytes resides in a subpopulation of CD43+ T cells.
    Wang HC; Montufar-Solis D; Teng BB; Klein JR
    J Immunol; 2004 Nov; 173(10):6294-302. PubMed ID: 15528368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome.
    Park JK; Rosenstein YJ; Remold-O'Donnell E; Bierer BE; Rosen FS; Burakoff SJ
    Nature; 1991 Apr; 350(6320):706-9. PubMed ID: 2023632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEM-59 monoclonal antibody detects a CD43 epitope involved in lymphocyte activation.
    Alvarado M; Klassen C; Cerny J; Horejsí V; Schmidt RE
    Eur J Immunol; 1995 Apr; 25(4):1051-5. PubMed ID: 7537669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression characteristics and stimulatory functions of CD43 in human CD4+ memory T cells: analysis using a monoclonal antibody to CD43 that has a novel lineage specificity.
    Kyoizumi S; Ohara T; Kusunoki Y; Hayashi T; Koyama K; Tsuyama N
    J Immunol; 2004 Jun; 172(12):7246-53. PubMed ID: 15187099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1.
    Rosenstein Y; Park JK; Hahn WC; Rosen FS; Bierer BE; Burakoff SJ
    Nature; 1991 Nov; 354(6350):233-5. PubMed ID: 1683685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polar redistribution of the sialoglycoprotein CD43: implications for T cell function.
    Savage ND; Kimzey SL; Bromley SK; Johnson KG; Dustin ML; Green JM
    J Immunol; 2002 Apr; 168(8):3740-6. PubMed ID: 11937524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD43 is a murine T cell costimulatory receptor that functions independently of CD28.
    Sperling AI; Green JM; Mosley RL; Smith PL; DiPaolo RJ; Klein JR; Bluestone JA; Thompson CB
    J Exp Med; 1995 Jul; 182(1):139-46. PubMed ID: 7790813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of T cell homing by CD43.
    Stockton BM; Cheng G; Manjunath N; Ardman B; von Andrian UH
    Immunity; 1998 Mar; 8(3):373-81. PubMed ID: 9529154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse.
    Allenspach EJ; Cullinan P; Tong J; Tang Q; Tesciuba AG; Cannon JL; Takahashi SM; Morgan R; Burkhardt JK; Sperling AI
    Immunity; 2001 Nov; 15(5):739-50. PubMed ID: 11728336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory role of CD43 leukosialin on integrin-mediated T-cell adhesion to endothelial and extracellular matrix ligands and its polar redistribution to a cellular uropod.
    Sánchez-Mateos P; Campanero MR; del Pozo MA; Sánchez-Madrid F
    Blood; 1995 Sep; 86(6):2228-39. PubMed ID: 7545023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of T-cell adhesion and activation by CD43.
    Manjunath N; Correa M; Ardman M; Ardman B
    Nature; 1995 Oct; 377(6549):535-8. PubMed ID: 7566153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.